BioCentury
ARTICLE | Clinical News

GeneMax preclinical data

July 26, 2004 7:00 AM UTC

In a mouse model of lung cancer, the TAP-1 cancer vaccine increased survival rate and tumor-specific immune responses and also retarded tumor growth. Data were presented at the International Congress ...